Systemic and medicinal use of essential oil (Amritbindu) in common cold

Pharmaceutical and analytical study of amrutmindu

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/10/037129

Enrollment

Registered

2021-10-06

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J00- Acute nasopharyngitis [common cold] Health Condition 2: J00- Acute nasopharyngitis [common cold]

Interventions

Intervention1: Pharmaceutical and analytical study of amrutmindu ( liquid roll on): Use of amrutmindu as external therapy for 5 days Control Intervention1: Not applicable: Not applicable

Eligibility

Inclusion criteria

Inclusion criteria: Patient willing for trial. Only uncomplicated case of cold

Exclusion criteria

Exclusion criteria: Patient not willing for trail. Patient presenting with complication like reaction with oil or sensitive skin.

Design outcomes

Primary

Measure	Time frame
To evaluate the effecacy of amritbindu in common coldTimepoint: 5-7 days	—

Secondary

Measure	Time frame
Use of amritbindu in pations of comman coldTimepoint: 6-8 month	—

Countries

India

Contacts

Public ContactPallavi jagnade

Parul institute of ayurveda

drjayaprakashan@gmail.com9019284633

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026